Glaukos (GKOS) Total Current Liabilities (2014 - 2026)
Glaukos (GKOS) posted quarterly Total Current Liabilities of $102.3 million for Q2 2026, up 29.31% year-over-year from $79.1 million in Q2 2025, and up 14.44% quarter-over-quarter from $89.4 million in Q1 2026.
Glaukos (GKOS) Total Current Liabilities (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Total Current Liabilities for 13 consecutive years, with $102.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 29.31% year-over-year to $102.3 million; the TTM figure through Jun 2026 stood at $102.3 million (up 29.31% YoY), while the FY2025 annual figure was $101.3 million, up 34.81% from the prior year.
- Total Current Liabilities advanced to $102.3 million in Q2 2026 per GKOS's latest filing, from $89.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $102.3 million in Q2 2026 and bottomed at $55.6 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $74.6 million across 5 years, with a median of $72.0 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities plunged 83.43% — and 2025, when it soared 34.81%.
- Glaukos' Total Current Liabilities stood at $72.4 million in 2022, then advanced by 2.29% to $74.0 million in 2023, then increased by 1.5% to $75.1 million in 2024, then soared by 34.81% to $101.3 million in 2025, then climbed by 1.04% to $102.3 million in 2026.
- Business Quant data shows GKOS's Total Current Liabilities at $102.3 million in Q2 2026, $89.4 million in Q1 2026, and $101.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Glaukos | 10.91 Bn | 10.80 Bn | 151.59 Mn | 102.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 102.33 Mn |
| Mar 31, 2026 | 89.42 Mn |
| Dec 31, 2025 | 101.28 Mn |
| Sep 30, 2025 | 87.52 Mn |
| Jun 30, 2025 | 79.14 Mn |
| Mar 31, 2025 | 68.53 Mn |
| Dec 31, 2024 | 75.13 Mn |
| Sep 30, 2024 | 71.68 Mn |
| Jun 30, 2024 | 70.08 Mn |
| Mar 31, 2024 | 72.24 Mn |
| Dec 31, 2023 | 74.01 Mn |
| Sep 30, 2023 | 67.15 Mn |
| Jun 30, 2023 | 63.89 Mn |
| Mar 31, 2023 | 62.39 Mn |
| Dec 31, 2022 | 72.36 Mn |
| Sep 30, 2022 | 60.62 Mn |
| Jun 30, 2022 | 69.51 Mn |
| Mar 31, 2022 | 55.60 Mn |
| Dec 31, 2021 | 63.36 Mn |
| Sep 30, 2021 | 63.45 Mn |